DEZENBRI Trademark

Trademark Overview

On Saturday, August 27, 2016, a trademark application was filed for DEZENBRI with the United States Patent and Trademark Office. The USPTO has given the DEZENBRI trademark a serial number of 79195695. The federal status of this trademark filing is CANCELLED - SECTION 71 as of Friday, December 29, 2023. This trademark is owned by Boehringer Ingelheim International GmbH. The DEZENBRI trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders
dezenbri

General Information

Serial Number79195695
Word MarkDEZENBRI
Filing DateSaturday, August 27, 2016
Status709 - CANCELLED - SECTION 71
Status DateFriday, December 29, 2023
Registration Number5220476
Registration DateTuesday, June 13, 2017
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 28, 2017

Trademark Statements

Goods and ServicesPharmaceutical preparations, namely, pharmaceutical preparations for the treatment of diseases and disorders of the alimentary tract and metabolism, and blood and blood forming organs; pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular system, musculoskeletal system, central nervous system, peripheral nervous system, genitourinary system and respiratory system; pharmaceutical preparations for the treatment of dermatological, hormonal, infectious, viral and oncological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status CodeF - NOT AVAILABLE
Class Status DateFriday, December 29, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameBoehringer Ingelheim International GmbH
Party Type30 - Original Registrant
Legal Entity Type27 - NOT AVAILABLE
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type20 - Owner at Publication
Legal Entity Type27 - NOT AVAILABLE
AddressDE
Party NameBoehringer Ingelheim International GmbH
Party Type10 - Original Applicant
Legal Entity Type27 - NOT AVAILABLE
AddressDE

Trademark Events

Event DateEvent Description
Thursday, November 10, 2016SN ASSIGNED FOR SECT 66A APPL FROM IB
Tuesday, November 15, 2016LIMITATION FROM ORIGINAL APPLICATION ENTERED
Friday, December 30, 2016REFUSAL PROCESSED BY IB
Thursday, February 2, 2017TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, November 16, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, November 22, 2016APPLICATION FILING RECEIPT MAILED
Friday, December 2, 2016ASSIGNED TO EXAMINER
Monday, December 5, 2016NON-FINAL ACTION WRITTEN
Tuesday, December 6, 2016NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, December 9, 2016REFUSAL PROCESSED BY MPU
Friday, December 9, 2016NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Monday, January 16, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Wednesday, March 8, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Wednesday, March 8, 2017NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 8, 2017NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Tuesday, March 28, 2017PUBLISHED FOR OPPOSITION
Tuesday, March 28, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, June 13, 2017REGISTERED-PRINCIPAL REGISTER
Thursday, February 2, 2017ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 3, 2017TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, February 3, 2017CORRESPONDENCE RECEIVED IN LAW OFFICE
Saturday, February 4, 2017TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 16, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Saturday, March 25, 2017NOTIFICATION PROCESSED BY IB
Wednesday, September 13, 2017FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, September 20, 2017FINAL DISPOSITION NOTICE SENT TO IB
Monday, June 13, 2022COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Friday, December 29, 2023CANCELLED SECTION 71
Friday, August 30, 2024TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
Tuesday, September 10, 2024TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
Tuesday, September 10, 2024INVALIDATION PROCESSED
Wednesday, September 20, 2017FINAL DISPOSITION PROCESSED
Saturday, October 28, 2017FINAL DECISION TRANSACTION PROCESSED BY IB

Related Keywords

dezenbri system pharmaceutical preparations diseases disorders treatment blood nervous peripheral genitourinary